BIOGROUP, a leading player in the French biotechnology sector, is headquartered in France and operates extensively across Europe. Founded in 2003, the company has established itself as a pioneer in the field of medical diagnostics and laboratory services, focusing on innovative solutions that enhance patient care.
With a diverse portfolio that includes clinical biology, genetic testing, and specialised laboratory services, BIOGROUP stands out for its commitment to quality and precision. The company has achieved significant milestones, including the expansion of its laboratory network and the introduction of cutting-edge diagnostic technologies.
Recognised for its excellence in the industry, BIOGROUP continues to strengthen its market position through strategic partnerships and a dedication to research and development, ensuring it remains at the forefront of the biotechnology landscape.
+11 vs industry average
BIOGROUP’s score of 34 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at BIOGROUP?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Laboratories has below-average carbon intensity
Industry performance
The Medical Laboratories industry has reduced its overall emissions by 17% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
BIOGROUP's reported carbon emissions
In 2024, BIOGROUP reported total carbon emissions of approximately 760.4 million kg CO2e, comprising 13.7 million kg CO2e from Scope 1, 3.3 million kg CO2e from Scope 2, and about 743.5 million kg CO2e from Scope 3 emissions. This represents a significant increase from 2023, when total emissions were approximately 410.0 million kg CO2e, with Scope 1 emissions at 3.7 million kg CO2e, Scope 2 at 0.7 million kg CO2e, and Scope 3 at about 405.7 million kg CO2e. BIOGROUP is committed to reducing its carbon footprint, with specific near-term targets set for Scope 1 and Scope 2 emissions. The company aims to achieve these reductions between 2023 and 2025, actively contributing to climate change mitigation efforts. It is important to note that BIOGROUP's emissions data is cascaded from its parent company, SCM BIOGROUP, reflecting a corporate family relationship. This data is crucial for understanding the overall environmental impact and commitments of the organisation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
BIOGROUP’s Climate Goals (2030 & 2050)
2 goals2025
Nous nous engageons résolument dans cette démarche pour cont…
Nous nous engageons résolument dans cette démarche pour contribuer activement à la lutte contre le changement climatique et à la préservatio…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
BIOGROUP
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project